Search results for " name" in Articles / App Notes
Article
Changing the Culture of Cell Culture: Applying Best Practices and Authentication to Ensure Scientific Reproducibility
By Leonard P. Freedman, Mark C. Gibson, Richard M. Neve
Irreproducible preclinical research is a global, expensive, and well-recognized problem that contributes to delays and increased costs of …
Article
Continuous Chromatography: Trends, Definitions and Approaches
As this movement is seen periodically, one could argue that the name Periodic Counter Current (PCC) is the most appropriate to describe what is really happening in a multicolumn system. However, for t…
Article
Moving Biosimilars Forward in a Hesitant Market
“Pricing pressure can come from lower priced, brand name biologics when they come off patent, it can come from competing biosimilars, but that’s the market. It’s not exactly like the generics market, …
Article
BetaLife Wins Cytiva's First BioChallenge Competition in Southeast Asia
BetaLife was named as the winner of the first BioChallenge in Southeast Asia on May 19, 2023.
Read full article
Article
Reimagining Affordable Biosimilars
It is a resourceful tool at different stages of biosimilar development, namely, clone selection (e.g., clonal proteome variations, product confirmation, sequence, glycosylation, residue modifications)…
Article
Emerging Therapies Test Existing Bioanalytical Methods
This leaves investigators asking questions about how to demonstrate the key bioanalytical attributes specified in the guidance, namely demonstrating that the method measures the intended analyte, eval…
Article
Advances in Engineering of Protein-Based APIs
But to effectively combat disease, many future drugs will require multiple proteins being agonized or antagonized to achieve efficacy, namely in the immune-oncology and inflammation space,” Stevens ex…
Article
Recent Advances in the Use of Exoglycosidases to Improve Structural Profiling of N-glycans from Biologic Drugs
The result was a new web utility named GlycanAnalyzer, developed in a collaboration between New England Biolabs and the Bioprocessing Technology Institute (A*STAR, Singapore). The program automates an…
Article
Ensuring Viral Safety of Viral Vaccines and Vectors
Because of the risks associated with live and inactivated viruses, namely potential attenuation reversal or failure of inactivation, recombinant viruses have emerged in the role of either vaccines or …
Article
Leveraging Data for Better Biopharmaceutical Process Control
IFPAC 2018 already showed this year several talks on MS-based multiple attribute methods (MAM), a new acronym being used by FDA’s Emerging Technology Team (ETT) to name the PAT use of these methods.
…